Many adults with diabetes are unaware of their increased risk for certain serious illnesses, according to a recent national, online consumer awareness survey sponsored by Merck and the American Diabetes Association, and conducted by Harris Poll. In the survey of 1,003 U.S. adults ages 18 years and older diagnosed with diabetes, respondents were twice as...
According to a story in Tuesday’s USA Today, the first artificial pancreas systems are beginning to come to market. The artificial pancreas is a nickname given to wearable devices that take on the dual task of monitoring glucose levels as well as administering insulin. Also referred to as a “closed-loop” system because the devices do...
Sticker Shock: An Inconvenient Truth About Healthcare Prices
Diabetes patients already feel the daily health burden of their disease. However, the rising costs of their medical care are also taking a toll. While endocrinologists understand the problems and have solutions, getting those solutions implemented is the ultimate challenge. Irl B. Hirsch, MD, professor of medicine at the University of Washington in Seattle runs... The Endocrine Society praised the decision to extend access to therapeutic continuous glucose monitors (CGMs) to older Americans on intensive insulin therapy for diabetes. The Centers for Medicare & Medicaid Services (CMS) announced new coverage criteria for CGM devices Thursday. The guidance states that all Medicare individuals who have type 1 or type 2 diabetes...
Five-Year Results of STAMPEDE Trial Show Bariatric Surgery’s Efficacy on Treating T2D
Researchers at Cleveland Clinic last month published the five-year results of STAMPEDE, a groundbreaking trial that compared intensive medical treatment and surgical treatment of uncontrolled type 2 diabetes (T2D). The results, published in the New England Journal of Medicine, showed that bariatric surgery plus intensive medical intervention was more effective in treating T2D than intensive...
As the numbers of people with cardiovascular disease and diabetes are on the rise, so is the research on how to treat these comorbidities together. While no one treatment can apply to all patients, helping patients make proper lifestyle choices appears to be the key to longevity. Cardiovascular disease (CVD) is the leading cause of... Curing type 1 diabetes in six years is the new goal of Duarte, Calif., based City of Hope’s Diabetes and Metabolism Research Institute. Through the generosity of the Wanek family and gifts from anonymous donors, the institution will be able to devote more than $50 million over the next six years to an innovative research...
- Endocrine News
- Member News
- Bone and Mineral
- Diabetes Research Articles
- Endocrine Disruptors
- Reproductive Issues
USA Today‘s Diagnosis: Diabetes Magazine—Dollars & Cents: Experts suggest ways to offset rising insulin costs Clinical Affairs Core Committee Chair Robert Lash, MD, discussed the importance of using diabetes medications as directed in the national newspaper’s digital magazine on diabetes. Le Monde —Perturbateurs endocriniens : la fabrique d’un mensonge (Endocrine disrupters: the manufacture of a...
Diabetes Research Articles
Get the most up to date news on diabetes research and treatment. For more information read the latest issue of Endocrine News.
